(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Grab Holdings, Bath & Body Works, and Abercrombie & Fitch's Earnings Preview

August 22nd, 2023

Several companies are gearing up to unveil their financial results on Wednesday, August 23, including: Grab Holdings Limited (Nasdaq: GRAB), a significant player in the technology and ride-hailing industry, is set to release its unaudited second q. Read more

Earnings Reactions: Toll Brothers and Urban Outfitters Beat Estimates

August 22nd, 2023

Toll Brothers, Inc. (NYSE: TOL), a prominent luxury homebuilder, reported third-quarter fiscal 2023 earnings of $3.73 per share, surpassing the consensus EPS estimate of $2.81. The company's quarterly sales reached $2.69 billion, exceeding analysts' . Read more

FDA’s Decision Boosts Fulcrum Therapeutics; Macy’s Beats Q2 Estimates

August 22nd, 2023

Shares of Fulcrum Therapeutics, Inc. (Nasdaq: FULC) surged over 30% in pre-market trading following the announcement that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Investigational New Drug (IND) application for F. Read more

Breaking: Microsoft's Reconstructed Activision Bid Under UK's CMA Examination

August 22nd, 2023

The UK's Competition and Markets Authority (CMA) has initiated a phase 1 investigation into Microsoft Corporation's (Nasdaq: MSFT) restructured deal to acquire Activision Blizzard, Inc. (Nasdaq: ATVI). This comes after the CMA previously blocked the . Read more

Baidu and iQIYI Outperform Wall Street Expectations

August 22nd, 2023

Baidu, Inc. (Nasdaq: BIDU), a leading Chinese technology company, unveiled second-quarter 2023 earnings per American depositary share (ADS) of $3.11, outperforming the consensus estimate of $2.32. The company's quarterly sales reached $4.70 billion, . Read more

Lockheed Martin Bags $347M+ Contract Modification; Nordson Posts Mixed Results, Outlook Disappoints

August 22nd, 2023

Lockheed Martin Aeronautics Company, a major division of Lockheed Martin Corporation (NYSE: LMT), has secured a $347,435,068 firm-fixed-price modification to a previously awarded indefinite-delivery/indefinite-quantity contract. This addition expands. Read more

$20.4M Financing Fuels ProMIS Neurosciences; Dragonfly Energy Misses Estimates

August 21st, 2023

Shares of ProMIS Neurosciences Inc. (Nasdaq: PMN) surged over 20% in after-hours trading following the announcement of a private investment financing for gross proceeds of approximately $20.4 million. The financing is set to conclude on August 23, 20. Read more

Earnings Breakthrough: Fabrinet and Zoom Video Outperform Expectations

August 21st, 2023

Fabrinet (NYSE: FN), a prominent provider of optical and electronic manufacturing services, unveiled fourth-quarter fiscal 2023 earnings of $1.86 per share, surpassing the consensus EPS estimate of $1.80. The company's quarterly sales totaled $655.87. Read more

Breaking: UK's CMA Greenlights Broadcom’s Acquisition of VMware

August 21st, 2023

In a significant development, the UK's Competition and Markets Authority (CMA) has given its green light to Broadcom Inc.'s (Nasdaq: AVGO) ambitious $69 billion acquisition of VMware, Inc. (NYSE: VMW), following a comprehensive Phase 2 investigation.. Read more

Bullish Views for XPeng and Blueprint Medicines

August 21st, 2023

XPeng Inc. (NYSE: XPEV), a leading Chinese electric vehicle manufacturer, received a boost in investor sentiment as BofA Securities upgraded the company from Neutral to Buy and raised the price target from $16.30 to $22.00. Considering that $XPEV . Read more